FATE vs SHOP · rev $3.4M vs P/E 107, rev $3.58B
Fate Therapeutics Inc (FATE) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
Latest reported SHOP revenue for 2026-06-30 was $3.58B. Net income was $1.50B. Revenue was up 13.0% from 2026-03-31 to 2026-06-30. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
FATE currently screens at market cap $331.0M. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the FATE and SHOP stock pages for the full models.
Not investment advice.